Table 5.
Risk factors for mortality of patients.
Candidemia Non-COVID-19 |
Candidemia COVID-19 |
Non-candidemia COVID-19 |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | P -value | Exp(B) | 95% CI | B | P -value | Exp(B) | 95% CI | B | P -value | Exp(B) | 95% CI | ||||
Age | 0.203 | 0.346 | 1.225 | 0.804 | 1.867 | 0.214 | 0.466 | 1.238 | 0.697 | 2.200 | 0.516 | 0.016 | 1.675 | 1.099 | 2.553 |
Gender | −0.295 | 0.173 | 0.745 | 0.487 | 1.138 | 0.222 | 0.429 | 1.249 | 0.720 | 2.166 | 0.240 | 0.235 | 1.271 | 0.856 | 1.887 |
SIRSa ≥ 2 | 10.963 | 0.999 | 57722.723 | 0.000 | 11.327 | 1.000 | 83022.238 | 0.000 | 0.723 | 0.018 | 2.060 | 1.129 | 3.757 | ||
Mechanical ventilation | 1.572 | 0.009 | 4.818 | 1.487 | 15.612 | 1.572 | 0.009 | 4.818 | 1.487 | 15.612 | 4.990 | 0.000 | 147.000 | 28.957 | 746.239 |
Day of treatment for candidemia | −0.275 | 0.017 | 0.760 | 0.606 | 0.953 | −0.204 | 0.206 | 0.816 | 0.595 | 1.119 | – | - | – | – | – |
Charlson comorbidity index | 0.165 | 0.025 | 1.179 | 1.021 | 1.362 | 0.040 | 0.763 | 1.041 | 0.804 | 1.347 | 0.344 | 0.003 | 1.411 | 1.124 | 1.771 |
Central venous catheterization | 0.588 | 0.232 | 1.800 | 0.687 | 4.719 | −0.260 | 0.755 | 0.771 | 0.151 | 3.929 | 1.277 | 0.003 | 3.587 | 1.542 | 8.349 |
Hypotension | 1.961 | 0.002 | 7.104 | 2.061 | 24.490 | 2.217 | 0.001 | 9.178 | 2.391 | 35.226 | 3.595 | 0.001 | 36.414 | 4.658 | 284.660 |
SIRS, systemic inflammatory response syndrome.